Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
Pharmaceutical formulations and methods for the topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namely, viral infections, such as Type I or Type II Herpes simplex infections and genital and...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
01.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pharmaceutical formulations and methods for the topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namely, viral infections, such as Type I or Type II Herpes simplex infections and genital and perianal warts, actinic deratosis and superficial basal cell carcinoma, and to induce interferon biosynthesis to achieve an antiviral effect, with shorter durations of therapy, than currently approved for imiquimod by the Food & Drug Administration ("FDA"). |
---|---|
Bibliography: | Application Number: US201314091589 |